Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Therapeutic Meibomian Gland Expression

NCT04997135 is registered in ClinicalTrials.gov with Johnson & Johnson Vision Care, Inc. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04997135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Therapeutic Meibomian Gland Expression
Lead sponsor
Johnson & Johnson Vision Care, Inc.
Phase
Observational
Overall status
Completed
Start date
August 15, 2021
Completion date
November 11, 2021
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

meibomian gland, visual acuity